Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

CStone Pharmaceuticals Director's Dealing 2022

Jun 17, 2022

50715_rns_2022-06-17_75630153-9cbe-42d0-9f90-635839de1997.pdf

Director's Dealing

Open in viewer

Opens in your device viewer

==> picture [173 x 58] intentionally omitted <==

Public Disclosure Form

17 June 2022

Possible offer

Disclosure of dealings in the shares of Yankuang Energy Group Company Limited

The Executive received the following disclosure of securities dealings pursuant to Rule 22 of the Hong Kong Code on Takeovers and Mergers:

Party Date Descriptionof relevantsecurities Nature of dealings Purchase/ Sale Totalnumber ofsharesinvolved Total amountpaid / received Highest (H)prices paid/ received Lowest (L)prices paid/ received
CICC PuchengInvestment Co.,Ltd. 16 June2022 Other typesof securities(e.g. equityswaps) Closing / flattening / unwinding ofproprietary positions arising fromunsolicited client-driven dealings. Iconfirm this was done no later thanthe close of the morning tradingsession on the trading day followingthe orginating client-driven dealing Sale 10,000 $263,000.0000 $26.3000 $26.3000

==> picture [71 x 43] intentionally omitted <==

Public Disclosure Form

Other typesof securities(e.g. equityswaps) Closing / flattening / unwinding ofproprietary positions arising fromunsolicited client-driven dealings. Iconfirm this was done no later thanthe close of the morning tradingsession on the trading day followingthe orginating client-driven dealing Purchase 10,000 $263,494.0500 $26.3494 $26.3494

End

Note:

CICC Pucheng Investment Co., Ltd. is an exempt principal trader connected with the Offeror. Dealings were made for its own account.

CICC Pucheng Investment Co., Ltd. is ultimately owned by China International Capital Corporation Limited.